Related Experiment Video
Updated: May 10, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Clinical Subtypes of Frontotemporal Dementia
Sayantani Ghosh1, Carol F Lippa2
1Department of Neurology, Drexel University College of Medicine, Philadelphia, PA, USA 87sayantani@gmail.com.
Summary
Frontotemporal dementia (FTD) is a neurodegenerative disorder with genetic and pathological roots. This review covers FTD subtypes, diagnosis, treatments, and caregiver challenges.
Area of Science:
- Neurology
- Neuroscience
- Genetics
Background:
- Frontotemporal dementia (FTD) is increasingly recognized due to advances in understanding its genetic and pathological basis.
- It is a common neurodegenerative disorder presenting with distinct clinical subtypes.
Purpose of the Study:
- To review the pathology, genetics, clinical and histological presentation of FTD subtypes.
- To discuss diagnostic approaches and current therapeutic options for FTD.
- To explore challenges faced by caregivers and future research directions.
Main Methods:
- Literature review of existing research on frontotemporal dementia.
- Synthesis of information on genetic factors, pathology, and clinical manifestations.
- Analysis of diagnostic criteria and therapeutic strategies.
Main Results:
- FTD has three main subtypes: behavioral variant, semantic dementia, and progressive non-fluent aphasia.
- The behavioral variant is characterized by personality changes, while semantic and progressive non-fluent aphasia involve language deficits.
- Current understanding covers pathology, genetics, diagnosis, and available treatments, alongside caregiver challenges.
Conclusions:
- Comprehensive understanding of FTD subtypes is crucial for accurate diagnosis and management.
- Therapeutic strategies are evolving, and caregiver support remains a significant consideration.
- Further research is needed to improve FTD diagnosis and treatment efficacy.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.